1. Erythrocytosis in the general population: clinical characteristics and association with clonal hematopoiesis

   Wouters, H. J. C. M., Mulder, R., van Zeventer, I. A., Schuringa, J. J., van der Klauw, M. M., van der Harst, P., Diepstra, A., Mulder, A. B. & Huls, G., 22-Dec-2020, In : Blood. 4, 24, p. 6353-6363 11 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Efficacy of MSC for steroid-refractory acute GVHD associates with MSC donor age and a defined molecular profile

   van der Wagen, L. E., Miranda-Bedate, A., Janssen, A., Fernando, F., Appukudige, N., van Dooremalen, S., Westinga, K., Admiraal, R., Lorenowicz, M. J., Huls, G., Janssen, J. J. W. M., Broers, A. E. C., van der Velden, W. J. F. M., van Marwijk Kooy, R., Hazenberg, M. D., de Haar, C., Lindemans, C., Jan Boelens, J. & Kuball, J., Nov-2020, In : Bone marrow transplantation. 55, 11, p. 2188-2192 5 p.

   Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

3. The IL1-IL1RAP axis plays an important role in the inflammatory leukemic niche that favors acute myeloid leukemia proliferation over normal hematopoiesis.

   De Boer, B., Sheveleva, S., Apelt, K., Vellenga, E., Mulder, A. B., Huls, G. & Schuringa, J. J., 29-Oct-2020, In : Haematologica. Online ahead of print, p. 0 46 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. The long road: improving outcome in elderly "unfit" AML?

   Lowenberg, B. & Huls, G., 11-Jun-2020, In : Blood. 135, 24, p. 2114-2115 3 p.

   Research output: Contribution to journal › Editorial › Academic › peer-review

5. Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study

   Cruijsen, M., van der Velden, W. J. F. M., de Haan, A. F. J., Klein, S. K., Hoogendoorn, M., Tromp, Y., de Valk, B., van Rees, B., de Boer, F., van der Spek, E., Pruijt, J., Verdonck, L. F., Vellenga, E., Blijlevens, N., van de Loosdrecht, A. A. & Huls, G., Nov-2020, In : Leukemia & Lymphoma. 61, 11, p. 2752-2755 4 p.

   Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

View all (89) »

1. HOVON (External organisation)

   Geert Huls (Member)

   2018

   Activity: Membership › Membership of board › Professional

2. HOVON (External organisation)

   Geert Huls (Member)

   2018

   Activity: Membership › Membership of board › Professional

3. Advisory board

   Geert Huls (Speaker)

   2018

   Activity: Talk or presentation › Professional

View all (9) »